BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21755575)

  • 1. Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesis.
    Numasawa Y; Kimura T; Miyoshi S; Nishiyama N; Hida N; Tsuji H; Tsuruta H; Segawa K; Ogawa S; Umezawa A
    Stem Cells; 2011 Sep; 29(9):1405-14. PubMed ID: 21755575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function.
    Shinmura D; Togashi I; Miyoshi S; Nishiyama N; Hida N; Tsuji H; Tsuruta H; Segawa K; Tsukada Y; Ogawa S; Umezawa A
    Stem Cells; 2011 Feb; 29(2):357-66. PubMed ID: 21732492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
    Wang S; Qin X; Sun D; Wang Y; Xie X; Fan W; Wang Y; Liang D; Pei X; Cao F
    Cell Biochem Funct; 2012 Oct; 30(7):574-81. PubMed ID: 22592978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function.
    Otto Beitnes J; Oie E; Shahdadfar A; Karlsen T; Müller RM; Aakhus S; Reinholt FP; Brinchmann JE
    Cell Transplant; 2012; 21(8):1697-709. PubMed ID: 22410280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes.
    Tsuji H; Miyoshi S; Ikegami Y; Hida N; Asada H; Togashi I; Suzuki J; Satake M; Nakamizo H; Tanaka M; Mori T; Segawa K; Nishiyama N; Inoue J; Makino H; Miyado K; Ogawa S; Yoshimura Y; Umezawa A
    Circ Res; 2010 May; 106(10):1613-23. PubMed ID: 20508201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
    Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
    Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
    Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
    J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient cardiomyogenic differentiation of bone marrow mesenchymal stromal cells by combination of Wnt11 and bone morphogenetic protein 2.
    Zhang Z; Li H; Ma Z; Feng J; Gao P; Dong H; Zhang Z
    Exp Biol Med (Maywood); 2012 Jul; 237(7):768-76. PubMed ID: 22829700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
    Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
    Huang F; Li ML; Fang ZF; Hu XQ; Liu QM; Liu ZJ; Tang L; Zhao YS; Zhou SH
    Cardiology; 2013; 125(1):18-30. PubMed ID: 23615185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.
    Pasha Z; Wang Y; Sheikh R; Zhang D; Zhao T; Ashraf M
    Cardiovasc Res; 2008 Jan; 77(1):134-42. PubMed ID: 18006467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
    Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction.
    Cai A; Zheng D; Dong Y; Qiu R; Huang Y; Song Y; Jiang Z; Rao S; Liao X; Kuang J; Dai G; Mai W
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):857-66. PubMed ID: 21983658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats.
    Hou M; Yang KM; Zhang H; Zhu WQ; Duan FJ; Wang H; Song YH; Wei YJ; Hu SS
    Int J Cardiol; 2007 Feb; 115(2):220-8. PubMed ID: 16889848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
    Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
    Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-independent cardiomyogenic transdifferentiation in human endometrium-derived mesenchymal cells.
    Ikegami Y; Miyoshi S; Nishiyama N; Hida N; Okamoto K; Miyado K; Segawa K; Ogawa S; Umezawa A
    Artif Organs; 2010 Apr; 34(4):280-8. PubMed ID: 20420609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J; Zhou W; Zheng W; Ma Y; Lin L; Tang T; Liu J; Yu J; Zhou X; Hu J
    Cardiology; 2007; 107(1):17-29. PubMed ID: 16741354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatocyte growth factor did not enhance the effects of bone marrow-derived mesenchymal stem cells transplantation on cardiac repair in a porcine acute myocardial infarction model].
    Ma DC; Yang ZJ; Wang W; Xu SL; Zhang YQ; Zhou F; Chen B; Xu ZQ; Cao KJ; Ma WZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):119-22. PubMed ID: 16626576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.